Recent Life Sciences Patent Cases: Sound The Alarm?

Law360, New York (December 6, 2012, 4:21 PM EST) -- First, there was Mayo v. Prometheus,[1] where the Supreme Court found the medical diagnostic methods at issue were not patentable subject matter. Then, the court sent Myriad[2] back to the Federal Circuit, for further consideration of whether isolated DNA sequences are patentable. It will soon hear that case again — certiorari was just granted.

The Supreme Court has also granted review in Bowman v. Monsanto[3] on whether patent exhaustion applies to self-replicating plant seed technologies. And now, a new petition is pending before the Supreme Court...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.